Feasibility of iFlow color-coding technique in quantitative real-time measurement of hemodynamic changes after transarterial chemoembolization for hepatocellular carcinoma

Feasibility of iFlow color-coding technique in quantitative real-time measurement of hemodynamic changes after transarterial chemoembolization for hepatocellular carcinoma

Objective To investigate the value of iFlow color-coding technique in quantitative real-time analysis of hemodynamic changes after transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). Methods A total of 31 patients who were diagnosed with HCC in Shanghai Fifth People′s Hospital...

Full description

Bibliographic Details
Main Author:	WANG Yuzhe
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2018-01-01
Series:	Linchuang Gandanbing Zazhi
Subjects:	carcinoma hepatocellular; chemoembolization therapeutic; angiography digital subtraction
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=8688

Similar Items

Balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: History, background, and the roles
by: Toshiyuki Irie, et al.
Published: (2020-01-01)

Research advances in transarterial chemoembolization combined with sorafenib in treatment of advanced hepatocellular carcinoma
by: WU Lei, et al.
Published: (2018-04-01)

Risk Factors for Liver Function Deterioration after Transarterial Chemoembolization Refractoriness in Child-Pugh Class A Hepatocellular Carcinoma Patients
by: Kang Hyun Park, et al.
Published: (2020-03-01)

Gallbladder Perforation after Transarterial Chemoembolization in a Patient with a Huge Hepatocellular Carcinoma
by: Min Young Son, et al.
Published: (2020-07-01)

Clinical outcomes of patients with a single hepatocellular carcinoma less than 5 cm treated with transarterial chemoembolization
by: Min Young Baek, et al.
Published: (2019-11-01)

Research advances in Huai′er granules combined with transarterial chemoembolization in treatment of hepatocellular carcinoma
by: DONG Deshuo
Published: (2017-10-01)

Addition of n-butyl cyanoacrylate to classic transarterial chemoembolization may improve the radiological response in patients with hepatocellular carcinoma
by: Lucas Moretti Monsignore, et al.
Published: (2015-12-01)

Risk Factors for the Development of Postembolization Syndrome after Transarterial Chemoembolization for Hepatocellular Carcinoma Treatment
by: Mariana Lima, et al.
Published: (2018-01-01)

Radiological response in Saudi patients undergoing transarterial chemoembolization for hepatocellular carcinoma
by: Al Fuhaid Turki, et al.
Published: (2007-01-01)

Determination of Risk Factors for Pain After Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma
by: Wang TC, et al.
Published: (2020-03-01)

Comparison between C-arm cone beam computed tomography and interventional angiography in transarterial chemoembolization of hepatocellular carcinoma
by: Ibraheim Ahmed Diab, et al.
Published: (2019-11-01)

Hepatobronchial Fistula and Lung Abscess after Transarterial Chemoembolization
by: Kwanjoo Lee, et al.
Published: (2017-05-01)

Transarterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin-Loaded Tandem Drug-Eluting Embolics
by: Boris Guiu, et al.
Published: (2019-07-01)

Utility of C-arm CT in overcoming challenges in patients undergoing Transarterial chemoembolization for hepatocellular carcinoma
by: Chinmay Kulkarni, et al.
Published: (2014-02-01)

A Rare Complication Following Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Wei-Chen Lin, et al.
Published: (2015-12-01)

Single-session combined radiofrequency ablation and transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Mahmoud A. Dawoud, et al.
Published: (2017-12-01)

Efficacy and safety of transarterial chemoembolization combined to conformal radiotherapy for uninodular hepatocellular carcinoma
by: Philippe Merle, et al.
Published: (2014-12-01)

Safety and efficacy assessment of transarterial chemoembolization using drug-eluting beads in patients with hepatocellular carcinoma and arterioportal shunt: a single-center experience
by: Xiao YD, et al.
Published: (2019-02-01)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
by: Zhang W, et al.
Published: (2021-07-01)

Radiomics Analysis Based on Contrast-Enhanced MRI for Prediction of Therapeutic Response to Transarterial Chemoembolization in Hepatocellular Carcinoma
by: Ying Zhao, et al.
Published: (2021-03-01)

Role of drug-eluting beads versus conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Mahmoud Abu Elfadl, et al.
Published: (2019-01-01)

Assessment of the relationship between hepatocellular carcinoma location and its response to transarterial chemoembolization
by: Ahmed Elsahhar, et al.
Published: (2021-09-01)

Outcome of conventional transarterial chemoembolization (cTACE) in the management of spontaneously ruptured hepatocellular carcinoma
by: Yashwant Patidar, et al.
Published: (2019-04-01)

Factors Predicting Survival after Transarterial Chemoembolization of Unresectable Hepatocellular Carcinoma
by: Farina M. Hanif, et al.
Published: (2014-10-01)

Outcome of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
by: Hadeel A Helmi, et al.
Published: (2020-01-01)

Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres
by: Waleed M. Hetta, et al.
Published: (2014-09-01)

Intraductal migration of necrotic hepatocellular carcinoma: A possible cause of obstructive cholangitis after chemoembolization
by: Hyo Jung Park, et al.
Published: (2018-04-01)

Clinical effect of transarterial chemoembolization combined with radiofrequency ablation in treatment of rabbit VX2 liver tumors
by: LI Hao, et al.
Published: (2018-04-01)

Ultraselective conventional transarterial chemoembolization: When and how?
by: Shiro Miyayama
Published: (2019-12-01)

Prognostic factors for transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
by: MA Shijie, et al.
Published: (2016-01-01)

Obstructive Jaundice Following Transarterial Chemoembolization for Hepatocellular Carcinoma with Bile Duct Invasion
by: Kazuki Matsushita, et al.
Published: (2021-06-01)

Rupture of hepatocellular carcinoma after transcatheter arterial chemoembolization: A case report
by: Hye Hyeon Moon, et al.
Published: (2021-01-01)

Effect of postoperative adjuvant transarterial chemoembolization on postoperative survival of patients with liver cancer and related influencing factors for prognosis
by: XING Zhixiang
Published: (2017-12-01)

Efficacy and Safety of Supplemental Transarterial Chemoembolization Through Extrahepatic Collateral Arteries with Drug-eluting Beads: Treatment for Unresectable Hepatocellular Carcinoma
by: Chiu SH, et al.
Published: (2020-11-01)

Efficacy of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma before hepatectomy:
by: GAO Sheng
Published: (2014-09-01)

Efficacy And Safety Of Raltitrexed Plus Oxaliplatin-Based Transarterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma
by: Shao W, et al.
Published: (2019-11-01)

Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study
by: Yanqiao Ren, et al.
Published: (2019-10-01)

Intraarterial Lidocaine Administration for Pain Control by Water-in-Oil Technique in Transarterial Chemoembolization: in vivo and Randomized Clinical Trial
by: Wang LZ, et al.
Published: (2021-10-01)

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
by: Hyun Young Woo, et al.
Published: (2015-12-01)

Gallbladder actinomycosis: Is it a complication after radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma?
by: Han Hyung, et al.
Published: (2011-06-01)

Cannot write session to /tmp/vufind_sessions/sess_71b4a7i5fa0vbteivb54rkf62l